Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEVATOMOX: Raltitrexed vs FOLFOX6 in mCRC
NCT01532804Phase 2Terminated
- Sponsor
- Institut du Cancer de Montpellier
- Start
- Jul 2011
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of raltitrexed in metastatic colorectal cancer (mCRC), sponsored by Institut du Cancer de Montpellier. Started Jul 2011; status: terminated.
02
Drugs
raltitrexed
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT01532804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01532804.